COSCIENS Biopharma Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -401.8% | -401.8% | -78.8% |
| FY2017 | 603.5% | 603.5% | -75.7% |
| FY2018 | 219.6% | 219.6% | 16.7% |
| FY2019 | 245.3% | 245.3% | -30.2% |
| FY2020 | -38.7% | -38.7% | -13.8% |
| FY2021 | -38.1% | -38.1% | -10.4% |
| FY2022 | 14.5% | 14.5% | 12.4% |
| FY2023 | -16.6% | -16.6% | -14.7% |
| FY2024 | -116.3% | -116.3% | -43.7% |
| FY2025 | -269.6% | -269.6% | -48.3% |